20-4248008-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000678.4(ADRA1D):c.950G>A(p.Gly317Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000623 in 1,557,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G317W) has been classified as Uncertain significance.
Frequency
Consequence
NM_000678.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADRA1D | NM_000678.4 | c.950G>A | p.Gly317Glu | missense_variant | 1/2 | ENST00000379453.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADRA1D | ENST00000379453.6 | c.950G>A | p.Gly317Glu | missense_variant | 1/2 | 1 | NM_000678.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000328 AC: 50AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000261 AC: 41AN: 157152Hom.: 0 AF XY: 0.000246 AC XY: 21AN XY: 85254
GnomAD4 exome AF: 0.000655 AC: 921AN: 1405066Hom.: 0 Cov.: 31 AF XY: 0.000618 AC XY: 429AN XY: 694138
GnomAD4 genome AF: 0.000328 AC: 50AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | The c.950G>A (p.G317E) alteration is located in exon 1 (coding exon 1) of the ADRA1D gene. This alteration results from a G to A substitution at nucleotide position 950, causing the glycine (G) at amino acid position 317 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at